Skip to main content
. 2021 Dec 14;226(Suppl 1):S71–S78. doi: 10.1093/infdis/jiab452

Table 1.

Characteristics of Study Participants

Characteristic Patients With ARTI Included in Current Study
(n = 616)
Total RESCEU Study Population
(n = 1040)
Patients With RSV
(n = 36)
Patients With Influenza
(n = 56a)
Patients With Other ARTI
(n = 583)
Age
 Median, y (range) 75 (63–89) 71 (60–90) 75 (60–100) 75 (60–100)
 Age older than 75 y 20 (56) 25 (44) 302 (52) 562 (54)
Female sex 20 (56) 28 (49) 320 (55) 554 (54)
Comorbidityb
 Cardiovascular 7 (19) 10 (18) 121 (21) 212 (21)
 Lung 5 (14) 7 (12) 76 (13) 120 (12)
 Diabetes 2 (6) 5 (9) 59 (10) 80 (8)
Allergies, anyc 11 (29) 15 (27) 167 (29) 276 (27)
 Hay fever 3 (9) 2 (4) 32 (6) 59 (6)
 House dust mite 0 (0) 4 (7) 22 (4) 32 (3)
Pneumococcal vaccinationd 4 (12) 10 (21) 71 (14) 118 (13)
Influenza vaccinatione 30 (86 44 (79) 444 (79) 752 (76)
Smoking status
 Current smoker 3 (8) 5 (9) 35 (6) 80 (8)
 Former smoker 14 (39) 17 (30) 241 (41) 409 (39)

Data are No. (%) except where indicated. Numbers represent individual participants. Missing data < 1% is not shown; if more than 1% is missing, the percentages are given as footnote.

Abbreviations: ARTI, acute respiratory tract infection; RESCEU, Respiratory Syncytial Virus Consortium in Europe; RSV, respiratory syncytial virus.

aOne patient experienced 2 separate influenza B infections during follow-up.

bCardiovascular comorbidity included all arrhythmias, structural heart diseases, angina, and cardiac events such as infarction, percutaneous coronary intervention, and bypass surgery. Hypertension was not included in this definition. Lung disease included asthma, chronic obstructive pulmonary disease, chronic bronchitis, and emphysema. Diabetes was defined as either type.

cMissing n = 12 (2%).

dMissing n = 56 (10%).

eMissing n = 19 (3%).